Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Ser473 appears to be phosphorylated mainly by the rapamycin-insensitive mTOR complex mTORC2 (80).”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 7×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“The tyrosine residues phosphorylated in each substrate occur in specific sequence motifs; once phosphorylated, they serve as docking sites for intracellular molecules containing SH2 (Src homology 2) domains (1).”
BackgroundSelf-citationInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · cited 1×
“In part, variability may reflect the presence of three Akt isoforms (88).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“Hirosumi J, et al. A central role for JNK in obesity and insulin resistance.”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“PI-(3,4,5)P3 recruits the serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) to the plasma membrane through its PH domain and phosphorylates Thr308 on Akt (78, 79).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 5×
“Other AGC kinases activated downstream of PI3K include the protein kinase C (PKC) family, particularly PKC-ζ.”
BackgroundInfluentialElchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210 · cited 2×
“PTP-1b–deficient mice are resistant to diet-induced obesity, suggesting that PTP-1b deletion in the brain may influence energy uptake and expenditure via leptin signaling (52, 53).”
BackgroundLaplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,089 · cited 1×
“Akt phosphorylates a variety of substrates, including glycogen synthase kinase-3 (GSK3) (96), the forkhead (FOXO) transcription factors, cAMP regulatory element–binding protein (CREB) (87, 97, 98), and the GAP proteins TSC2, AS160, and RalGAPA (99).”
BackgroundRheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“IRS-2–deficient mice exhibit hepatic insulin resistance, with some growth defects in the brain, β cells, and retinal cells (45).”
BackgroundRommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling
Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J.-H., Masiarz, F., Kan, Y. W., Goldfine, I. D., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90334-4 · Cited by 1,477
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,303 · cited 1×
“Akt phosphorylates a variety of substrates, including glycogen synthase kinase-3 (GSK3) (96), the forkhead (FOXO) transcription factors, cAMP regulatory element–binding protein (CREB) (87, 97, 98), and the GAP proteins TSC2, AS160, and RalGAPA (99).”
BackgroundKohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252 · cited 1×
“IRS-1–deficient mice exhibit pre- and postnatal growth retardation due to IGF-1 resistance, as well as insulin resistance and impaired glucose tolerance, primarily in muscle and fat (43, 44).”
BackgroundKlaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y.-B., Sharpe, A. H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5479-5489.2000 · Cited by 1,235 · cited 1×
“PTP-1b–deficient mice are resistant to diet-induced obesity, suggesting that PTP-1b deletion in the brain may influence energy uptake and expenditure via leptin signaling (52, 53).”
BackgroundmTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229 · cited 2×
“The phosphatidic acid phosphatase and transcriptional coactivator lipin-1 is a direct substrate of mTORC1 and regulator of nuclear SREBP activity (197).”
BackgroundRegulated transport of the glucose transporter GLUT4
Bryant, N. J., Govers, R., & James, D. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm782 · Cited by 1,183
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · cited 1×
“Akt phosphorylates and inhibits the GTPase-activating protein (GAP) tuberosclerosis complex 2 (TSC2), which forms a complex with the scaffolding protein TSC1 that negatively controls the small GTPase Rheb, a key regulator of the mTORC1 complex (120, 121).”
BackgroundCrystal structure of the tyrosine kinase domain of the human insulin receptor
Hubbard, S. R., Wei, L., & Hendrickson, W. A. (1994) · Nature · doi:10.1038/372746a0 · Cited by 1,080 · cited 1×
“While substrates can interact with each domain, phosphorylation of the three sites within the kinase domain are key for activation, as revealed by crystal structures of the tyrosine kinase domain determined in several different phosphorylation states and with bound substrates (25, 26).”
BackgroundLawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071 · cited 2×
“Akt phosphorylates a variety of substrates, including glycogen synthase kinase-3 (GSK3) (96), the forkhead (FOXO) transcription factors, cAMP regulatory element–binding protein (CREB) (87, 97, 98), and the GAP proteins TSC2, AS160, and RalGAPA (99).”
BackgroundCheatham, B., Vlahos, C. J., Cheatham, L., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902 · Cited by 1,068 · cited 1×
“Control of phosphoinositide metabolism The enzyme PI3K is pivotal in the metabolic and mitogenic actions of insulin (67) (Figure 3), and PI3K inhibitors or targeted deletion tyrosine kinases have been identified (Figure 2).”
BackgroundStephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., McCormick, F., Tempst, P., et al. (1998) · Science · doi:10.1126/science.279.5351.710 · Cited by 1,059
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033 · cited 2×
“Because α/β heterodimers of insulin, IGF-1, and IRR receptors undergo activation by transphosphorylation, a dominant-negative mutant form of one receptor subtype can inhibit the other’s activity, explaining why individuals with insulin receptor mutations exhibit both metabolic insulin resistance and growth retardation…”
BackgroundPhosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation.
Backer, J. M., Myers, M. G., Shoelson, S. E., Chin, D. J., Sun, X. J., Miralpeix, M., Hu, P., Margolis, B., Skolnik, E. Y., & Schlessinger, J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05426.x · Cited by 1,008 · cited 1×
“The class 1 form of PI3K consists of a p85 regulatory unit (encoded by PIK3R1) and a p110 catalytic subunit (PIK3CA) and is activated by the two SH2 domains in the regulatory subunit interacting with tyrosine-phosphorylated IRS proteins (68, 69).”
BackgroundInsulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962 · cited 3×
“These Rabs have a positive role in GLUT4 translocation, suggesting that they may regulate GSV formation and/or intracellular retention (127–129).”
BackgroundHubbard, S. R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5572 · Cited by 953 · cited 1×
“While substrates can interact with each domain, phosphorylation of the three sites within the kinase domain are key for activation, as revealed by crystal structures of the tyrosine kinase domain determined in several different phosphorylation states and with bound substrates (25, 26).”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Regulation of glucose transport by insulin: traffic control of GLUT4
Leto, D., & Saltiel, A. R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3351 · Cited by 848 · cited 6×
“The rate-limiting step in insulin’s control of glucose homeostasis is stimulation of glucose transport in fat and muscle (99, 123, 124).”
BackgroundInfluentialSelf-citationShimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 793 · cited 2×
“(194) to speculate that increased expression of the isoform SREBP-1c might lead to “mixed insulin resistance” observed in the diabetic liver, with increased rates of both gluconeogenesis and lipogenesis.”
BackgroundKim, J. B., Sarraf, P., Wright, M., Yao, K. M., Mueller, E., Solanes, G., Lowell, B. B., & Spiegelman, B. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1411 · Cited by 792
Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401516101 · Cited by 785
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Ras proteins: different signals from different locations
Hancock, J. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1105 · Cited by 756 · cited 1×
“Once activated, Ras operates as a molecular switch, converting upstream tyrosine phosphorylation into a serine kinase cascade via stepwise activation of Raf and the MAPKs MEK, ERK1, and ERK2 (111, 112).”
BackgroundForetz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747 · cited 1×
“Dominant-negative forms of SREBP-1 can block lipogenic gene expression (191, 192), while SREBP-1 overexpression can increase it (194).”
BackgroundBiochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 6×
“PI3K catalyzes the phosphorylation of phosphoinositides on the 3-position to generate PI-(3)P, PI-(3,4)P2, and PI-(3,4,5)P3.”
BackgroundInfluentialLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726 · cited 1×
“Targeted deletion of Akt isoforms produces insulin resistance and glucose intolerance (83, 84), and Akt mutations have been identified in patients with severe insulin resistance (85), whereas an activating mutation produced hypoglycemia (86).”
BackgroundNew Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692 · cited 5×
“PI3K catalyzes the phosphorylation of phosphoinositides on the 3-position to generate PI-(3)P, PI-(3,4)P2, and PI-(3,4,5)P3.”
BackgroundInfluentialSelf-citationInsulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system
Kasuga, M., Zick, Y., Blithe, D. L., Crettaz, M., & Kahn, C. R. (1982) · Nature · doi:10.1038/298667a0 · Cited by 679
CAP defines a second signalling pathway required for insulin-stimulated glucose transport
Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Pessin, J. E., & Saltiel, A. R. (2000) · Nature · doi:10.1038/35025089 · Cited by 661 · cited 11×
“The best-characterized substrates are the IRS proteins Shc, SH2B2, and Cbl.”
BackgroundInfluentialSelf-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652 · cited 6×
“However, the primary mechanism controlling expression of hepatic gluconeogenic genes appears to involve FOXO1 (174, 175).”
BackgroundInfluentialNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Transcriptional regulation of hepatic lipogenesis
Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4074 · Cited by 646
Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“In humans, the indirect pathway may contribute to diabetes pathogenesis, especially in individuals with central obesity, since visceral fat is less sensitive than subcutaneous fat to insulin inhibition of lipolysis, resulting in direct flux of fatty acids through the portal vein to the liver (185).”
BackgroundInsulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10
Chiang, S.-H., Baumann, C. A., Kanzaki, M., Thurmond, D. C., Watson, R. T., Neudauer, C. L., Macara, I. G., Pessin, J. E., & Saltiel, A. R. (2001) · Nature · doi:10.1038/35073608 · Cited by 611 · cited 4×
“Upon phosphorylation, SH2B2 recruits a complex of SORBS1 and c-Cbl (38, 103), triggering insulin receptor–catalyzed tyrosine phosphorylation of c-Cbl, which then interacts with the adaptor protein Crk in complex with C3G, a guanyl nucleotide exchange factor (GEF) (104).”
BackgroundInfluentialSelf-citationMolecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 564
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559 · cited 1×
“Targeted deletion of Akt isoforms produces insulin resistance and glucose intolerance (83, 84), and Akt mutations have been identified in patients with severe insulin resistance (85), whereas an activating mutation produced hypoglycemia (86).”
BackgroundADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose
Foretz, M., Pacot, C., Dugail, I., Lemarchand, P., Guichard, C., le Lièpvre, X., Berthelier-Lubrano, C., Spiegelman, B., Kim, J. B., Ferré, P., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3760 · Cited by 548 · cited 1×
“Dominant-negative forms of SREBP-1 can block lipogenic gene expression (191, 192), while SREBP-1 overexpression can increase it (194).”
BackgroundThe role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540 · cited 1×
“Akt-mediated phosphorylation of FOXO1 inhibits its activity by retaining FOXO1 in the cytoplasm (176, 177).”
BackgroundCarpenter, C. L., & Cantley, L. C. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80060-3 · Cited by 534
A Method to Identify Serine Kinase Substrates
Kane, S., Sano, H., Liu, S. C. H., Asara, J. M., Lane, W. S., Garner, C. C., & Lienhard, G. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200198200 · Cited by 526 · cited 3×
“These Rabs have a positive role in GLUT4 translocation, suggesting that they may regulate GSV formation and/or intracellular retention (127–129).”
BackgroundFreychet, P., Roth, J., & Neville, D. M. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.8.1833 · Cited by 498 · cited 1×
“β Subunits in the mature receptor traverse the membrane via a helical structure, and the receptor is mostly found in the plasma membrane (12), although a fraction may be found in the nucleus (13, 14).”
BackgroundWhite, M. F., Shoelson, S. E., Keutmann, H., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69163-x · Cited by 476
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469 · cited 1×
“Despite pronounced insulin resistance, hepatocyte-specific knockout of the insulin receptor protects mice from fatty liver (187, 188).”
BackgroundDong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 1×
“Conversely, deleting FoxO1 in liver eliminates the requirement for direct insulin action to suppress glucose output (179, 181, 182).”
BackgroundMîinea, C. P., Sano, H., Kane, S., Sano, E., Fukuda, M., Peränen, J., Lane, W. S., & Lienhard, G. E. (2005) · Biochemical Journal · doi:10.1042/bj20050887 · Cited by 449 · cited 2×
“The Akt substrate AS160 is a RabGAP that targets Rab8 and Rab14 in muscle cells, and Rab10 in adipocytes (126, 127).”
BackgroundThe exocyst complex in polarized exocytosis
He, B., & Guo, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.007 · Cited by 438
Standaert, M. L., Galloway, L., Karnam, P., Bandyopadhyay, G., Moscat, J., & Farese, R. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30075 · Cited by 436
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R. B., Girard, J., & Postic, C. (2006) · Diabetes · doi:10.2337/db06-0200 · Cited by 433
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429 · cited 2×
“Insulin also counteracts glucagon action by decreasing transcription of FBP1 (encoding bisphosphatase) and G6P (glucose-6-phosphatase) and increases transcription of genes encoding glycolytic enzymes such as glucokinase and pyruvate kinase and lipogenic enzymes such as fatty acid synthase and acetyl-CoA carboxylase (1…”
BackgroundThe exocyst is a Ral effector complex
Moskalenko, S., Henry, D. O., Rosse, C., Mirey, G., Camonis, J. H., & White, M. A. (2002) · Nature Cell Biology · doi:10.1038/ncb728 · Cited by 423 · cited 1×
“Once activated, RalA interacts with exocyst subunits Sec5 and Exo84 (137, 143, 144).”
BackgroundRegulation of TORC1 in Response to Amino Acid Starvation via Lysosomal Recruitment of TSC2
Demetriades, C., Doumpas, N., & Teleman, A. A. (2014) · Cell · doi:10.1016/j.cell.2014.01.024 · Cited by 420 · cited 1×
“Akt phosphorylates and inhibits the GTPase-activating protein (GAP) tuberosclerosis complex 2 (TSC2), which forms a complex with the scaffolding protein TSC1 that negatively controls the small GTPase Rheb, a key regulator of the mTORC1 complex (120, 121).”
BackgroundGoldstein, B. J., Bittner-Kowalczyk, A., White, M. F., & Harbeck, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4283 · Cited by 419
Molecular Mechanism for the Regulation of Protein Kinase B/Akt by Hydrophobic Motif Phosphorylation
Yang, J., Cron, P., Thompson, V., Good, V. M., Hess, D., Hemmings, B. A., & Barford, D. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00550-6 · Cited by 418 · cited 1×
“S473 phosphorylation may be partially redundant but stabilizes Akt’s active conformation state (81).”
BackgroundMultisite and hierarchal protein phosphorylation
Roach, P. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98653-9 · Cited by 415 · cited 1×
“Hormonal activation of glycogen synthase involves both allosteric interaction with glucose-6-phosphate (152) and dephosphorylation promoted by kinase inhibition (including PKA, AMPK, or GSK3; refs.”
BackgroundZinker, B. A., Rondinone, C. M., Trevillyan, J. M., Gum, R. J., Clampit, J. E., Waring, J. F., Xie, N., Wilcox, D., Jacobson, P., Frost, L., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298199 · Cited by 414 · cited 1×
“Disrupting Ptpn in mice increases insulin-dependent tyrosine phosphorylation of the insulin receptor and IRS proteins, leading to improved insulin sensitivity (51, 52).”
BackgroundMcCormick, F. (1993) · Nature · doi:10.1038/363015a0 · Cited by 408
COMPARTMENTALIZED RAS/MAPK SIGNALING
Mor, A., & Philips, M. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090723 · Cited by 398 · cited 1×
“Once activated, Ras operates as a molecular switch, converting upstream tyrosine phosphorylation into a serine kinase cascade via stepwise activation of Raf and the MAPKs MEK, ERK1, and ERK2 (111, 112).”
BackgroundLazar, D. F., Wiese, R. J., Brady, M. J., Mastick, C. C., Waters, S. B., Yamauchi, K., Pessin, J. E., Cuatrecasas, P., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20801 · Cited by 396 · cited 2×
“Although it was proposed that MAPK activation leads to phosphorylation of the targeting protein GM to activate PP1 and dephosphorylate GS, blocking the pathway did not affect insulin’s activation of glycogen synthase, and mutating the identified phosphorylation sites did not impair insulin action (113).”
BackgroundSelf-citationInsulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2012) · Nature Medicine · doi:10.1038/nm.2686 · Cited by 395 · cited 1×
“Conversely, deleting FoxO1 in liver eliminates the requirement for direct insulin action to suppress glucose output (179, 181, 182).”
BackgroundOzes, O. N., Akca, H., Mayo, L. D., Gustin, J. A., Maehama, T., Dixon, J. E., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051042298 · Cited by 382
The lipid phosphatase SHIP2 controls insulin sensitivity
Clément, S., Krause, U., Desmedt, F., Tanti, J.-F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 376
Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6286 · Cited by 376 · cited 1×
“Although these phosphodiesterases can be phosphorylated and presumably regulated via Akt (166), Akt knockout did not compromise the insulin-mediated inhibition of HSL in adipocytes (167), indicating that the pathways responsible for this important action of insulin remain unknown.”
BackgroundGustafson, T. A., He, W., Craparo, A., Schaub, C. D., & O'Neill, T. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2500 · Cited by 375 · cited 11×
“The best-characterized substrates are the IRS proteins Shc, SH2B2, and Cbl.”
BackgroundInfluentialKotani, K., Ogawa, W., Matsumoto, M., Kitamura, T., Sakaue, H., Hino, Y., Miyake, K., Sano, W., Akimoto, K., Ohno, S., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6971 · Cited by 360 · cited 1×
“Overexpressing PKC-ζ or PKC-λ resulted in GLUT4 translocation (93, 94), whereas expressing a dominant-interfering PKC-λ blocked insulin action (95).”
BackgroundLesniak, M. A., & Roth, J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33403-8 · Cited by 357
The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin
Inoue, M., Chang, L., Hwang, J., Chiang, S.-H., & Saltiel, A. R. (2003) · Nature · doi:10.1038/nature01533 · Cited by 354 · cited 2×
“Once activated, TC10 binds to the exocyst scaffolding subunit Exo70, which assembles the complex at the plasma membrane (135, 136, 138, 139).”
BackgroundSelf-citationLavan, B. E., Lane, W. S., & Lienhard, G. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11439 · Cited by 349
Taylor, S. I. (1992) · Diabetes · doi:10.2337/diab.41.11.1473 · Cited by 344 · cited 1×
“1172/JCI142241 To date, over 100 INSR mutations have been discovered (27) that cause reduced biosynthesis of the receptor, impaired transport or recycling to the plasma membrane, decreased binding affinity, or reduced tyrosine kinase activity.”
BackgroundPostreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L., Jackson, S., Vottero, A., Kanabar, D., Charlton-Menys, V., Durrington, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 344 · cited 1×
“Observations that patients with insulin receptor loss-of-function mutations display extreme insulin resistance and hyperglycemia and are protected from developing fatty liver (189) support the essential role of direct insulin action in regulating overall hepatic lipid accumulation.”
BackgroundKlip, A., McGraw, T. E., & James, D. E. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.008351 · Cited by 344 · cited 1×
“The rate-limiting step in insulin’s control of glucose homeostasis is stimulation of glucose transport in fat and muscle (99, 123, 124).”
BackgroundSano, H., Eguez, L., Teruel, M. N., Fukuda, M., Chuang, T. D., Chavez, J. A., Lienhard, G. E., & McGraw, T. E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.001 · Cited by 340 · cited 2×
“The Akt substrate AS160 is a RabGAP that targets Rab8 and Rab14 in muscle cells, and Rab10 in adipocytes (126, 127).”
BackgroundGenetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile
Kilpeläinen, T. O., Zillikens, M. C., Stančákova, A., Finucane, F. M., Ried, J. S., Langenberg, C., Zhang, W., Beckmann, J. S., Luan, J., Vandenput, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.866 · Cited by 335 · cited 1×
“These polymorphisms are associated with insulin resistance, hyperinsulinemia, adiposity, dyslipidemia, and risk of coronary disease, along with reduced IRS-1 protein levels and decreased IRS-1–associated PI3K activity (65).”
BackgroundER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Kim, J. Y., Garcia-Carbonell, R., Yamachika, S., Zhao, P., Dhar, D., Loomba, R., Kaufman, R. J., Saltiel, A. R., & Karin, M. (2018) · Cell · doi:10.1016/j.cell.2018.08.020 · Cited by 333 · cited 1×
“It remains possible that additional signals generated in obesity, such as nutritional factors (amino acids, sugars), ER stress, inflammation, or other hormones or transcriptional pathways (including LXR), drive the lipogenic pathway in a manner that still requires insulin (195).”
BackgroundSelf-citationAminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus
Almind, K., Bjørbaek, C., Vestergaard, H., Hansen, T., Echwald, S., & Pedersen, O. (1993) · The Lancet · doi:10.1016/0140-6736(93)92694-o · Cited by 325 · cited 1×
“Several polymorphisms in human IRS-1 (G971R and A513P) observed in T2D produce decreased associated PI3K activity (64).”
BackgroundSer/Thr Phosphorylation of IRS Proteins: A Molecular Basis for Insulin Resistance
Zick, Y. (2005) · Science's STKE · doi:10.1126/stke.2682005pe4 · Cited by 320 · cited 1×
“IRS proteins and the insulin receptor also undergo serine phosphorylation that is generally associated with reduced insulin action (54).”
BackgroundA Role for Protein Kinase Bβ/Akt2 in Insulin-Stimulated GLUT4 Translocation in Adipocytes
Hill, M. M., Clark, S. F., Tucker, D. F., Birnbaum, M. J., James, D. E., & Macaulay, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7771 · Cited by 315
New Insights Into the Role and Mechanism of Glycogen Synthase Activation by Insulin
Lawrence, J. C., & Roach, P. J. (1997) · Diabetes · doi:10.2337/diab.46.4.541 · Cited by 311
Structure of the insulin receptor ectodomain reveals a folded-over conformation
McKern, N. M., Lawrence, M. C., Streltsov, V. A., Lou, M.-Z., Adams, T. E., Lovrecz, G. O., Elleman, T. C., Richards, K. M., Bentley, J. D., Pilling, P. A., et al. (2006) · Nature · doi:10.1038/nature05106 · Cited by 305 · cited 1×
“Crystallography of the unbound receptor/ ligand-binding domain dimer revealed an inverted U structure with about 115 Å distance between membrane insertion regions (20, 21).”
BackgroundMilarski, K. L., & Saltiel, A. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31954-3 · Cited by 302 · cited 1×
“Full activation of Ras by insulin also requires stimulation of the tyrosine phosphatase SHP2, which interacts with insulin receptor substrates including Gab-1 and IRS-1/2 (109, 110).”
BackgroundSelf-citationKerouz, N. J., Hörsch, D., Pons, S., & Kahn, C. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119872 · Cited by 302 · cited 1×
“p85α is ubiquitously expressed, while p55α and p50α play specific roles (71).”
BackgroundDe Fea, K., & Roth, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31400 · Cited by 298 · cited 2×
“Multiple intracellular kinases are implicated in this serine phosphorylation (7, 56), including some activated by insulin, such as Akt (57), JNK (58), ERK (59), and PI3K (60), which potentially provide feedback inhibition.”
BackgroundFruman, D. A., Mauvais-Jarvis, F., Pollard, D. A., Yballe, C. M., Brazil, D., Bronson, R. T., Kahn, C. R., & Cantley, L. C. (2000) · Nature Genetics · doi:10.1038/81715 · Cited by 293 · cited 1×
“In mice, disruption of all three Pik3r1 isoforms is lethal within a few weeks of birth, indicating the enzyme’s importance in normal growth and metabolism (72).”
BackgroundSasaoka, T., Rose, D. W., Jhun, B. H., Saltiel, A. R., Draznin, B., & Olefsky, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36885-0 · Cited by 291 · cited 1×
“Upon tyrosine phosphorylation, Shc interacts with the SH2/SH3 adaptor protein Grb2 to activate the Ras pathway (40, 46).”
BackgroundSelf-citationActivation of Protein Kinase C (α, β, and ζ) by Insulin in 3T3/L1 Cells
Bandyopadhyay, G., Standaert, M. L., Zhao, L., Yu, B., Avignon, A., Galloway, L., Karnam, P., Moscat, J., & Farese, R. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2551 · Cited by 288
Yamauchi, T., Tobe, K., Tamemoto, H., Ueki, K., Kaburagi, Y., Yamamoto-Honda, R., Takahashi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.3074 · Cited by 288 · cited 1×
“IRS-1–deficient mice exhibit pre- and postnatal growth retardation due to IGF-1 resistance, as well as insulin resistance and impaired glucose tolerance, primarily in muscle and fat (43, 44).”
BackgroundConnecting mTORC1 signaling to SREBP-1 activation
Bakan, I., & Laplante, M. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328352dd03 · Cited by 281 · cited 1×
“mTORC1 is the major downstream effector of Akt in the control of lipogenic gene expression (196); the mTORC1 inhibitor rapamycin blocks insulin-stimulated SREBP activation and lipogenesis.”
BackgroundTitchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 281 · cited 1×
“Conversely, deleting FoxO1 in liver eliminates the requirement for direct insulin action to suppress glucose output (179, 181, 182).”
BackgroundKim, S.-J., Tang, T., Abbott, M., Viscarra, J. A., Wang, Y., & Sul, H. S. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00244-16 · Cited by 277 · cited 6×
“Hormonal activation of glycogen synthase involves both allosteric interaction with glucose-6-phosphate (152) and dephosphorylation promoted by kinase inhibition (including PKA, AMPK, or GSK3; refs.”
BackgroundInfluentialProtein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
Yamauchi, K., Milarski, K. L., Saltiel, A. R., & Pessin, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.664 · Cited by 263 · cited 1×
“Full activation of Ras by insulin also requires stimulation of the tyrosine phosphatase SHP2, which interacts with insulin receptor substrates including Gab-1 and IRS-1/2 (109, 110).”
BackgroundSelf-citationMyers, M. G., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., & White, M. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61974-5 · Cited by 261 · cited 1×
“The class 1 form of PI3K consists of a p85 regulatory unit (encoded by PIK3R1) and a p110 catalytic subunit (PIK3CA) and is activated by the two SH2 domains in the regulatory subunit interacting with tyrosine-phosphorylated IRS proteins (68, 69).”
BackgroundRena, G., Prescott, A. R., Guo, S., Cohen, P., & Unterman, T. G. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540605 · Cited by 261 · cited 1×
“Akt-mediated phosphorylation of FOXO1 inhibits its activity by retaining FOXO1 in the cytoplasm (176, 177).”
BackgroundStahl, A., Evans, J. G., Pattel, S., Hirsch, D., & Lodish, H. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00143-0 · Cited by 259 · cited 1×
“The fatty acid transporters CD36 (146) and FATP1 (147) are both implicated, and studies show that insulin can increase the translocation of these transporters from intracellular vesicles to the cell surface (146) to enhance fatty acid uptake in fat and muscle cells (142, 147).”
BackgroundHepatic Insulin Clearance: Mechanism and Physiology
Najjar, S. M., & Perdomo, G. (2019) · Physiology · doi:10.1152/physiol.00048.2018 · Cited by 246
Gingras, A.-C., Raught, B., & Sonenberg, N. (2004) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-18930-2_11 · Cited by 246 · cited 1×
“mTOR’s phosphorylation of PHAS1 induces its dissociation from eIF-2, allowing cap-dependent translation of mRNAs with a highly structured 5′-untranslated region (122).”
BackgroundRal GTPases Regulate Exocyst Assembly through Dual Subunit Interactions
Moskalenko, S., Tong, C., Rosse, C., Mirey, G., Formstecher, E., Daviet, L., Camonis, J., & White, M. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308702200 · Cited by 238 · cited 1×
“Once activated, RalA interacts with exocyst subunits Sec5 and Exo84 (137, 143, 144).”
BackgroundStrålfors, P., Björgell, P., & Belfrage, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3317 · Cited by 232 · cited 3×
“Hormonal activation of glycogen synthase involves both allosteric interaction with glucose-6-phosphate (152) and dephosphorylation promoted by kinase inhibition (including PKA, AMPK, or GSK3; refs.”
BackgroundGlucose transporter 4: cycling, compartments and controversies: Third in the Cycles Review Series
Dugani, C. B., & Klip, A. (2005) · EMBO reports · doi:10.1038/sj.embor.7400584 · Cited by 230 · cited 1×
“The rate-limiting step in insulin’s control of glucose homeostasis is stimulation of glucose transport in fat and muscle (99, 123, 124).”
BackgroundGorden, P., Carpentier, J.-L., Freychet, P., LeCam, A., & Orci, L. (1978) · Science · doi:10.1126/science.644321 · Cited by 218
Hedo, J. A., Kahn, C. R., Hayashi, M., Yamada, K. M., & Kasuga, M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44600-x · Cited by 217 · cited 1×
“The receptor’s two subunits derive from a single precursor processed by a furin-like enzyme to produce an α/β subunit complex, which then undergoes disulfide linkage to form the tetramer (8, 10, 11).”
BackgroundA Novel, Multifunctional c-Cbl Binding Protein in Insulin Receptor Signaling in 3T3-L1 Adipocytes
Ribon, V., Printen, J. A., Hoffman, N. G., Kay, B. K., & Saltiel, A. R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.872 · Cited by 214
Self-citationSugimoto, S., Wandless, T. J., Shoelson, S. E., Neel, B. G., & Walsh, C. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36874-6 · Cited by 213
ChREBP regulates fructose-induced glucose production independently of insulin signaling
Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81993 · Cited by 212
Novel insights into ChREBP regulation and function
Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J., & Postic, C. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.01.003 · Cited by 210 · cited 12×
“Dietary fructose administration induces hepatic steatosis, an effect dependent on ChREBP (199).”
BackgroundInfluentialHaas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 210 · cited 1×
“Despite pronounced insulin resistance, hepatocyte-specific knockout of the insulin receptor protects mice from fatty liver (187, 188).”
BackgroundKnudsen, B. S., Feller, S. M., & Hanafusa, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)30059-4 · Cited by 208 · cited 1×
“C3G in turn activates the small GTPase TC10 (RhoQ) (105, 106).”
BackgroundChen, X.-W., Leto, D., Chiang, S.-H., Wang, Q., & Saltiel, A. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.07.007 · Cited by 205 · cited 3×
“Although the precise role of these two RalA-binding proteins remains uncertain, both are required for insulin-stimulated glucose uptake (137).”
BackgroundSelf-citationLi, J., DeFea, K., & Roth, R. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9351 · Cited by 199 · cited 1×
“Multiple intracellular kinases are implicated in this serine phosphorylation (7, 56), including some activated by insulin, such as Akt (57), JNK (58), ERK (59), and PI3K (60), which potentially provide feedback inhibition.”
BackgroundRibon, V., Johnson, J. H., Camp, H. S., & Saltiel, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14751 · Cited by 196 · cited 1×
“SORBS1 expression correlates well with insulin responsiveness and increases when cells are treated with insulinsensitizing thiazolidinediones (66, 107).”
BackgroundSelf-citationIrs1 Serine 307 Promotes Insulin Sensitivity in Mice
Copps, K. D., Hancer, N. J., Opare-Ado, L., Qiu, W., Walsh, C., & White, M. F. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.003 · Cited by 196 · cited 1×
“However, the physiological relevance of these negative phosphorylation events remains uncertain (62, 63).”
BackgroundCraparo, A., Freund, R., & Gustafson, T. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11663 · Cited by 196 · cited 1×
“Serine phosphorylation of the receptor or substrates blocks insulin action by decreasing tyrosine phosphorylation and sequestering tyrosines by promoting interaction with 14-3-3 proteins (55).”
BackgroundThe Tumor Suppressor PTEN Negatively Regulates Insulin Signaling in 3T3-L1 Adipocytes
Nakashima, N., Sharma, P. M., Imamura, T., Bookstein, R., & Olefsky, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12889 · Cited by 194 · cited 4×
“The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes.”
BackgroundInfluentialLechleider, R. J., Freeman, R. M., & Neel, B. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38668-5 · Cited by 191 · cited 2×
“Other direct substrates include Gab-1 (35), DOK1 (36), Cbl (37), SH2B2 (APS) (38), SHP2 (39), and the various isoforms of Shc (40), each of which initiates a signaling pathway.”
BackgroundNew Insights into mTOR Signaling: mTORC2 and Beyond
Alessi, D. R., Pearce, L. R., & García-Martínez, J. M. (2009) · Science Signaling · doi:10.1126/scisignal.267pe27 · Cited by 189
Newgard, C. B., Brady, M. J., O'Doherty, R. M., & Saltiel, A. R. (2000) · Diabetes · doi:10.2337/diabetes.49.12.1967 · Cited by 189 · cited 1×
“The compartmentalized, insulin-mediated activation of PP1 is due to glycogen-targeting subunits that serve as molecular scaffolds, incorporating the enzyme with its substrates in a macromolecular complex (149).”
BackgroundSelf-citationCritical Role for Hypothalamic mTOR Activity in Energy Balance
Mori, H., Inoki, K., Münzberg, H., Opland, D., Faouzi, M., Villanueva, E. C., Ikenoue, T., Kwiatkowski, D., MacDougald, O. A., Myers, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.005 · Cited by 187
Coordinated action of protein tyrosine phosphatases in insulin signal transduction
Cheng, A., Dubé, N., Gu, F., & Tremblay, M. L. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2002.02756.x · Cited by 187
An Activating Mutation of AKT2 and Human Hypoglycemia
Hussain, K., Challis, B., Rocha, N., Payne, F., Minic, M., Thompson, A., Daly, A., Scott, C., Harris, J., Smillie, B. J. L., et al. (2011) · Science · doi:10.1126/science.1210878 · Cited by 178 · cited 1×
“Targeted deletion of Akt isoforms produces insulin resistance and glucose intolerance (83, 84), and Akt mutations have been identified in patients with severe insulin resistance (85), whereas an activating mutation produced hypoglycemia (86).”
BackgroundLiu, J., Kimura, A., Baumann, C. A., & Saltiel, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3599-3609.2002 · Cited by 168 · cited 7×
“Hu J, Liu J, Ghirlando R, Saltiel AR, Hubbard SR. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor.”
BackgroundInfluentialSelf-citationInsulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 164
Ogihara, T., Isobe, T., Ichimura, T., Taoka, M., Funaki, M., Sakoda, H., Onishi, Y., Inukai, K., Anai, M., Fukushima, Y., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25267 · Cited by 162 · cited 1×
“Moreover, serine kinases activated in obesity or by inflammation, especially PKCε (7), can phosphorylate and inhibit substrate tyrosine phosphorylation (61).”
BackgroundInsulin signaling in fatty acid and fat synthesis: a transcriptional perspective
Wong, R. H., & Sul, H. S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.08.004 · Cited by 160 · cited 1×
“Insulin also counteracts glucagon action by decreasing transcription of FBP1 (encoding bisphosphatase) and G6P (glucose-6-phosphatase) and increases transcription of genes encoding glycolytic enzymes such as glucokinase and pyruvate kinase and lipogenic enzymes such as fatty acid synthase and acetyl-CoA carboxylase (1…”
BackgroundInsulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression
Hancock, M. L., Meyer, R. C., Mistry, M., Khetani, R. S., Wagschal, A., Shin, T., Ho Sui, S. J., Näär, A. M., & Flanagan, J. G. (2019) · Cell · doi:10.1016/j.cell.2019.02.030 · Cited by 158 · cited 1×
“β Subunits in the mature receptor traverse the membrane via a helical structure, and the receptor is mostly found in the plasma membrane (12), although a fraction may be found in the nucleus (13, 14).”
BackgroundMechanisms regulating phosphoinositide 3‐kinase signalling in insulin‐sensitive tissues
Shepherd, P. R. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01382.x · Cited by 153 · cited 8×
“Although it was proposed that MAPK activation leads to phosphorylation of the targeting protein GM to activate PP1 and dephosphorylate GS, blocking the pathway did not affect insulin’s activation of glycogen synthase, and mutating the identified phosphorylation sites did not impair insulin action (113).”
BackgroundInfluentialValentine, R. J., Coughlan, K. A., Ruderman, N. B., & Saha, A. K. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.08.013 · Cited by 151 · cited 6×
“Hormonal activation of glycogen synthase involves both allosteric interaction with glucose-6-phosphate (152) and dephosphorylation promoted by kinase inhibition (including PKA, AMPK, or GSK3; refs.”
BackgroundInfluentialBinding of insulin to isolated nuclei.
Goldfine, I. D., & Smith, G. J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.5.1427 · Cited by 151 · cited 1×
“β Subunits in the mature receptor traverse the membrane via a helical structure, and the receptor is mostly found in the plasma membrane (12), although a fraction may be found in the nucleus (13, 14).”
BackgroundHinoda, Y., Neumaier, M., Hefta, S. A., Drzeniek, Z., Wagener, C., Shively, L., Hefta, L. J., Shively, J. E., & Paxton, R. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6959 · Cited by 150
Wiese, R. J., Mastick, C. C., Lazar, D. F., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3442 · Cited by 150 · cited 2×
“Activation of PI3K with other hormones, such as PDGF and IL-4, does not stimulate glucose transport in adipocytes (92).”
BackgroundSelf-citationMembrane-permeant Esters of Phosphatidylinositol 3,4,5-Trisphosphate
Jiang, T., Sweeney, G., Rudolf, M. T., Klip, A., Traynor‐Kaplan, A., & Tsien, R. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11017 · Cited by 148 · cited 1×
“Likewise, adding a PI-(3,4,5)trisphosphate (PIP3) analog alone did not effect glucose transport (101), and two insulin receptor mutants that produced complete PI3K activation failed to mediate full insulin action (102).”
BackgroundCompartmentalization of the Exocyst Complex in Lipid Rafts Controls Glut4 Vesicle Tethering
Inoue, M., Chiang, S.-H., Chang, L. C., Chen, X., & Saltiel, A. R. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0030 · Cited by 144 · cited 1×
“Once activated, TC10 binds to the exocyst scaffolding subunit Exo70, which assembles the complex at the plasma membrane (135, 136, 138, 139).”
BackgroundSelf-citationCroll, T. I., Smith, B. J., Margetts, M. B., Whittaker, J., Weiss, M. A., Ward, C. W., & Lawrence, M. C. (2016) · Structure · doi:10.1016/j.str.2015.12.014 · Cited by 144 · cited 1×
“Crystallography of the unbound receptor/ ligand-binding domain dimer revealed an inverted U structure with about 115 Å distance between membrane insertion regions (20, 21).”
BackgroundJones, C. N. O., Pei, D., Staris, P., Polonsky, K. S., Chen, Y. I., & Reaven, G. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3979 · Cited by 139
Wu, H., Turner, C., Gardner, J., Temple, B., & Brennwald, P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0501 · Cited by 136 · cited 2×
“Moreover, targeted knockout of Exo70 blocks glucose uptake in vivo (138).”
BackgroundBrady, M., Bourbonais, F., & Saltiel, A. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14063 · Cited by 134 · cited 1×
“PP1 activation correlates well with changes in glycogen synthase activity (160).”
BackgroundSelf-citationOkamoto, H., Obici, S., Accili, D., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23096 · Cited by 133
Rab10 in insulin-stimulated GLUT4 translocation
Sano, H., Roach, W. G., Peck, G. R., Fukuda, M., & Lienhard, G. E. (2008) · Biochemical Journal · doi:10.1042/bj20071318 · Cited by 133 · cited 1×
“Insulin-mediated activation of Rab8 and Rab14 was observed in muscle cells, but Rab10 activation has not been detected (129, 132).”
BackgroundHøjlund, K., Hansen, T., Lajer, M., Henriksen, J. E., Levin, K., Lindholm, J., Pedersen, O., & Beck-Nielsen, H. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1592 · Cited by 130
Visualization of ligand-induced transmembrane signaling in the full-length human insulin receptor
Gutmann, T., Kim, K. H., Grzybek, M., Walz, T., & Coskun, Ü. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201711047 · Cited by 129 · cited 2×
“Importantly, single-particle cryo-EM of full-length insulin receptor corroborated this finding (22).”
BackgroundExocyst dynamics during vesicle tethering and fusion
Ahmed, S. M., Nishida‐Fukuda, H., Li, Y., McDonald, W. H., Gradinaru, C. C., & Macara, I. G. (2018) · Nature Communications · doi:10.1038/s41467-018-07467-5 · Cited by 127 · cited 1×
“GLUT4 tethering relies on the exocyst, an evolutionarily conserved octameric complex that assembles at sites of exocytosis and tethers exocytic vesicles on the plasma membrane (133, 134).”
BackgroundInsulin/receptor binding: The last piece of the puzzle?
MEYTS, P. D. (2015) · BioEssays · doi:10.1002/bies.201400190 · Cited by 126 · cited 1×
“At least nine intracellular substrates of insulin and IGF-1 receptor ing induces the conformational changes that lead to tyrosine kinase activation (19).”
BackgroundLipid phosphatases as drug discovery targets for type 2 diabetes
Lazar, D. F., & Saltiel, A. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2007 · Cited by 125 · cited 1×
“This pathway can be terminated by phosphoinositide phosphatases (73), such as PTEN (74) and SHIP2 (encoded by Inppl1) (75).”
BackgroundSelf-citationMorino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125 · cited 1×
“However, the physiological relevance of these negative phosphorylation events remains uncertain (62, 63).”
BackgroundAndjelković, M., Maira, S.-M., Cron, P. D., Parker, P. J., & Hemmings, B. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5061 · Cited by 121 · cited 1×
“Once activated at the plasma membrane, phosphorylated Akt can translocate to the cytoplasm or nucleus, depending on cell type (100).”
BackgroundInsulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116 · cited 6×
“A central component of metabolic syndrome’s pathophysiology is insulin resistance, produced by reduced responsiveness to insulin in fat, liver, muscle, and other tissues (4).”
BackgroundInfluentialSelf-citationStructural Basis for Recruitment of the Adaptor Protein APS to the Activated Insulin Receptor
Hu, J., Liu, J., Ghirlando, R., Saltiel, A. R., & Hubbard, S. R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00487-8 · Cited by 116 · cited 3×
“SH2B2 is the insulin receptor’s highest-affinity substrate (38, 47).”
BackgroundSelf-citationvon Wilamowitz-Moellendorff, A., Hunter, R. W., García-Rocha, M., Kang, L., López‐Soldado, I., Lantier, L., Patel, K., Peggie, M. W., Martínez-Pons, C., Voß, M., et al. (2013) · Diabetes · doi:10.2337/db13-0880 · Cited by 116
Ribon, V., Hubbell, S. E., Herrera, R., & Saltiel, A. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.45 · Cited by 116 · cited 4×
“Upon phosphorylation, SH2B2 recruits a complex of SORBS1 and c-Cbl (38, 103), triggering insulin receptor–catalyzed tyrosine phosphorylation of c-Cbl, which then interacts with the adaptor protein Crk in complex with C3G, a guanyl nucleotide exchange factor (GEF) (104).”
BackgroundInfluentialSelf-citationRandhawa, V. K., Ishikura, S., Talior‐Volodarsky, I., Cheng, A. W.-P., Patel, N., Hartwig, J. H., & Klip, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804282200 · Cited by 115
The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin
DiPilato, L. M., Ahmad, F., Harms, M., Seale, P., Manganiello, V. C., & Birnbaum, M. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00422-15 · Cited by 113 · cited 1×
“Although these phosphodiesterases can be phosphorylated and presumably regulated via Akt (166), Akt knockout did not compromise the insulin-mediated inhibition of HSL in adipocytes (167), indicating that the pathways responsible for this important action of insulin remain unknown.”
BackgroundA Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action
Chen, X.-W., Leto, D., Xiong, T., Yu, G., Cheng, A., Decker, S., & Saltiel, A. R. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0665 · Cited by 108 · cited 2×
“RalGAP function requires RalGAPB, and deleting RalGAPB leads to RalGAPA instability (140).”
BackgroundSelf-citationEffects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo
Edgerton, D. S., Ramnanan, C. J., Grueter, C. A., Johnson, K., Lautz, M., Neal, D. W., Williams, P. E., & Cherrington, A. D. (2009) · Diabetes · doi:10.2337/db09-0328 · Cited by 103 · cited 1×
“Hepatic nuclear factor-3 (HNF3) and HNF4 both appear to be involved in regulating PEPCK expression (169, 172).”
BackgroundHypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes
Bergman, R. N., Piccinini, F., Kabir, M., Kolka, C. M., & Ader, M. (2019) · Diabetes · doi:10.2337/db19-0098 · Cited by 103
Turning down insulin signaling
Birnbaum, M. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13714 · Cited by 102 · cited 1×
“Multiple intracellular kinases are implicated in this serine phosphorylation (7, 56), including some activated by insulin, such as Akt (57), JNK (58), ERK (59), and PI3K (60), which potentially provide feedback inhibition.”
BackgroundChakravarty, K., Leahy, P. S., Bécard, D., Hakimi, P., Foretz, M., Ferré, P., Foufelle, F., & Hanson, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103310200 · Cited by 98 · cited 1×
“1172/JCI142241 binding protein-1c (SREBP-1c), which may also contribute to insulin’s negative effect on PEPCK transcription (173).”
BackgroundHaney, P. M., Levy, M. A., Strube, M., & Mueckler, M. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.3.641 · Cited by 92 · cited 1×
“Insulin markedly increases the rate of GLUT4 vesicle exocytosis (99, 125).”
BackgroundThe Insulin Receptor and Its Substrate: Molecular Determinants of Early Events in Insulin Action
Kahn, C. R., White, M. F., Shoelson, S. E., Backer, J., Araki, E., Cheatham, B., Csermely, P., Folli, F. B., Goldstein, B. J., Huertas, P. E., et al. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50015-4 · Cited by 91
Tanti, J., Grémeaux, T., OBBERGHEN, E. V., & MARCHAND‐BRUSTEL, Y. L. (1994) · Biochemical Journal · doi:10.1042/bj3040017 · Cited by 90 · cited 18×
“However, PI3K inhibitors can block insulin’s activation of PP1 (163), indicating that PIP3-dependent protein kinases are involved.”
BackgroundInfluentialMetabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity
Lu, B., Bridges, D., Yang, Y., Fisher, K., Cheng, A., Chang, L. C., Meng, Z., Lin, J. D., Downes, M., Yu, R. T., et al. (2014) · Diabetes · doi:10.2337/db13-1531 · Cited by 88
Self-citationKaisaki, P. J., Délepine, M., Woon, P. Y., Sebag‐Montefiore, L., Wilder, S. P., Menzel, S., Vionnet, N., Marion, E., Riveline, J., Charpentier, G., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1900 · Cited by 88 · cited 1×
“Polymorphisms in INPPL1 are associated with increased incidence of hypertension, obesity, T2D, and metabolic syndrome (76).”
BackgroundA Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
Wan, M., Leavens, K. F., Hunter, R. W., Koren, S., von Wilamowitz-Moellendorff, A., Lu, M., Satapati, S., Chu, Q., Sakamoto, K., Burgess, S. C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.001 · Cited by 87 · cited 2×
“GSK3 inhibition is not sufficient for full activation of glycogen, since GSK3 does not phosphorylate all of the residues of glycogen synthase that are dephosphorylated in response to insulin (157), and knockins of GSK3 mutants have failed to support this enzyme’s role in stimulating glycogen synthesis (158, 159).”
BackgroundThe Roles of Cbl-b and c-Cbl in Insulin-stimulated Glucose Transport
Liu, J., DeYoung, S. M., Hwang, J., O’Leary, E. E., & Saltiel, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300664200 · Cited by 86 · cited 1×
“SH2B2’s SH2 domain binds to the phosphorylated receptor kinase activation loop; once phosphorylated, SH2B2 binds to Cbl, permitting its phosphorylation on three tyrosines (38, 41).”
BackgroundSelf-citationBerman, H. K., O'Doherty, R. M., Anderson, P., & Newgard, C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26421 · Cited by 80 · cited 1×
“Overexpressing these scaffolding proteins dramatically increases glycogen levels (161).”
BackgroundRole of Protein Targeting to Glycogen (PTG) in the Regulation of Protein Phosphatase-1 Activity
Brady, M., Printen, J. A., Mastick, C. C., & Saltiel, A. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20198 · Cited by 80
Self-citationWick, M. J., Dong, L., Hu, D., Langlais, P. R., & Liu, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102116200 · Cited by 68 · cited 1×
“Other direct substrates include Gab-1 (35), DOK1 (36), Cbl (37), SH2B2 (APS) (38), SHP2 (39), and the various isoforms of Shc (40), each of which initiates a signaling pathway.”
BackgroundLehr, S., Kotzka, J., Herkner, A., Sikmann, A., Meyer, H. E., Krone, W., & Müller‐Wieland, D. (2000) · Biochemistry · doi:10.1021/bi000982k · Cited by 66 · cited 3×
“Other direct substrates include Gab-1 (35), DOK1 (36), Cbl (37), SH2B2 (APS) (38), SHP2 (39), and the various isoforms of Shc (40), each of which initiates a signaling pathway.”
BackgroundNew frontiers in insulin receptor substrate signaling
Myers, M. G., & White, M. F. (1995) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)00092-v · Cited by 60 · cited 1×
“IRS-1 and IRS-2 are widely distributed, whereas IRS-3 and IRS-4 expression is more limited (42).”
BackgroundKagawa, S., Sasaoka, T., Yaguchi, S., Ishihara, H., Tsuneki, H., Murakami, S., Fukui, K., Wada, T., Kobayashi, S., Kimura, I., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1724 · Cited by 55 · cited 1×
“A polymorphism in INPPL1’s catalytic domain identified in a Japanese population of diabetic subjects suggests possible protection from insulin resistance (77).”
BackgroundRalA controls glucose homeostasis by regulating glucose uptake in brown fat
Skorobogatko, Y., Dragan, M., Cordon, C., Reilly, S. M., Hung, C.-W., Xia, W., Zhao, P., Wallace, M., Lackey, D. E., Chen, X.-W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801050115 · Cited by 52 · cited 1×
“1172/JCI142241 leads to RalA activation in both adipocytes (141) and muscle (142), along with a dramatic increase in glucose uptake and improved glucose tolerance (142).”
BackgroundSelf-citationKrook, A., Moller, D. E., Dib, K., & O’Rahilly, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7134 · Cited by 49 · cited 1×
“Likewise, adding a PI-(3,4,5)trisphosphate (PIP3) analog alone did not effect glucose transport (101), and two insulin receptor mutants that produced complete PI3K activation failed to mediate full insulin action (102).”
BackgroundDynamics of Hepatic and Peripheral Insulin Effects Suggest Common Rate-Limiting Step In Vivo
Bradley, D. C., Poulin, R. A., & Bergman, R. N. (1993) · Diabetes · doi:10.2337/diab.42.2.296 · Cited by 48 · cited 1×
“This occurs via changes in the availability of gluconeogenesis substrates released from muscle and fat (184).”
BackgroundThe Forkhead Transcription Factor Foxo1
Farmer, S. R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00003-0 · Cited by 47 · cited 6×
“However, the primary mechanism controlling expression of hepatic gluconeogenic genes appears to involve FOXO1 (174, 175).”
BackgroundInfluentialLipid transporters: membrane transport systems for cholesterol and fatty acids
Abumrad, N. A., Sfeir, Z., Connelly, M. A., & Coburn, C. T. (2000) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200007000-00003 · Cited by 46 · cited 1×
“The fatty acid transporters CD36 (146) and FATP1 (147) are both implicated, and studies show that insulin can increase the translocation of these transporters from intracellular vesicles to the cell surface (146) to enhance fatty acid uptake in fat and muscle cells (142, 147).”
BackgroundAblooglu, A. J., & Kohanski, R. A. (2000) · Biochemistry · doi:10.1021/bi002292m · Cited by 46 · cited 1×
“Because α/β heterodimers of insulin, IGF-1, and IRR receptors undergo activation by transphosphorylation, a dominant-negative mutant form of one receptor subtype can inhibit the other’s activity, explaining why individuals with insulin receptor mutations exhibit both metabolic insulin resistance and growth retardation…”
BackgroundA Rab10:RalA G protein cascade regulates insulin-stimulated glucose uptake in adipocytes
Karunanithi, S., Xiong, T., Uhm, M., Leto, D. E., Sun, J., Chen, X., & Saltiel, A. R. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1060 · Cited by 46 · cited 8×
“Insulin stimulates AS160 phosphorylation via Akt, relieving AS160’s inhibitory effect on target Rabs (130, 131).”
BackgroundInfluentialSelf-citationChang, T., Wang, W., Hsiung, C. A., He, C., Lin, M., Sheu, W. H., Chang, Y., Quertermous, T., Chen, Y.-D. I., Rotter, J. I., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28891-z · Cited by 43 · cited 12×
“The best-characterized substrates are the IRS proteins Shc, SH2B2, and Cbl.”
BackgroundInfluentialKohanski, R. A. (1993) · Biochemistry · doi:10.1021/bi00073a008 · Cited by 42 · cited 1×
“Tyrosine autophosphorylation sites have been mapped in all three regions (23, 24).”
BackgroundBjörgell, P., Rosberg, S., Isaksson, O. G. P., & Belfrage, P. (1984) · Endocrinology · doi:10.1210/endo-115-3-1151 · Cited by 40 · cited 1×
“PKA (150) and AMPK (165) also regulate HSL activation via phosphorylation, while insulin inhibits HSL via a combination of kinase inhibition and phosphatase activation, and a major pathway involves reductions in cAMP levels due to the activation of the cAMP-specific phosphodiesterases PDE4 and PDE3B in fat cells (150,…”
BackgroundDobrosotskaya, I. Y., Goldstein, J. L., Brown, M. S., & Rawson, R. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306476200 · Cited by 36 · cited 1×
“Insulin negatively regulates Insig-2a mRNA expression in an Akt-dependent manner, resulting in decreased INSIG-2 protein (198).”
BackgroundSano, H., Peck, G. R., Blachon, S., & Lienhard, G. E. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.069 · Cited by 35 · cited 1×
“Once activated, TC10 binds to the exocyst scaffolding subunit Exo70, which assembles the complex at the plasma membrane (135, 136, 138, 139).”
Background
Research works printed but not linked: 2
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
Cited by
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 820
Mechanisms of Oxidative Stress in Metabolic Syndrome
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097898 · Cited by 717
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.